Search

Paris, France We are looking for passionate and driven scientists with expertise in synthetic biology to join our international and highly motivated team in Paris working on next-generation tools for editing the microbiome (engineered phage

Dr. Andrew Page, Norwich, UK The microbes that live inside our guts are mostly a mystery to science. We know they have an impact on our health and wellbeing that extends far beyond the gut but science currently doesn’t fully understand how

Dr. Andrew Page, Norwich, UK The microbes that live inside our guts are mostly a mystery to science. We know they have an impact on our health and wellbeing that extends far beyond the gut but science currently doesn’t fully understand how

Ness Ziona, Israel BiomX is a leading Israeli biotech company developing microbiome-based novel therapeutics. We are looking for a highly-motivated M.Sc.-level research assistant to join our Microbiology team. By joining this team, you will

A new paper by Bryan Hsu and colleagues at Harvard and Brigham and Women's Hospital showed (in the mouse gut) that introducing phages led to predictable shifts in the targeted population, but also had "cascading effects" on non-phage-suscep

BiomX, a phage therapy biotech company, just announced that it's licensed new bacterial targets for commercialization of phage therapies for Primary Sclerosing Cholangitis (PSC; a rare, progressive liver disease). The targets: strains of Kl

BiomX, a phage therapy biotech company, just announced that it's licensed new bacterial targets for commercialization of phage therapies for Primary Sclerosing Cholangitis (PSC; a rare, progressive liver disease). The targets: strains of Kl

A new paper by Bryan Hsu and colleagues at Harvard and Brigham and Women's Hospital showed (in the mouse gut) that introducing phages led to predictable shifts in the targeted population, but also had "cascading effects" on non-phage-suscep

UC Denver postdoc Dr. Anushila Chatterjee attended this year's Ohio State University Viromics Workshop. Here's her report on what was covered! ## Exploring the virus world, inside out Did you know that your body contains 100-fold more virus

Great news for BiomX, a company developing custom phage therapies to treat microbiome-based diseases, which just raised $32 million in series B financing!

virMine is a new phage bioinformatics tool by Andrea Garretto and colleagues at Loyola University of Chicago. Use virMine to identify viral genomes from raw reads representative of viral or mixed (viral and bacterial) communities. Paper | G

Dr. Jeremy Barr | The Barr Lab The Barr Lab research group is studying bacteriophages within the context of their bacterial and mammalian hosts. We are offering an excellent opportunity to engage in an exciting post-doc position that combin

virMine is a new phage bioinformatics tool by Andrea Garretto and colleagues at Loyola University of Chicago. Use virMine to identify viral genomes from raw reads representative of viral or mixed (viral and bacterial) communities. Paper | G

Dr. Jeremy Barr | The Barr Lab The Barr Lab research group is studying bacteriophages within the context of their bacterial and mammalian hosts. We are offering an excellent opportunity to engage in an exciting post-doc position that combin

Should phage therapy be considered for pregnant women? This week, Dr. Lucy Furfaro introduces the field of perinatal phage research. It’s an exciting time to be a phage researcher! Progress has been made at the basic science, clinical and p

We are seeking highly qualified investigators who use definitive approaches to understand the nature of the microbiome and its impact on host physiology and disease susceptibility. Candidates are sought with expertise in areas related to mi

We are seeking highly qualified investigators who use definitive approaches to understand the nature of the microbiome and its impact on host physiology and disease susceptibility. Candidates are sought with expertise in areas related to mi

Dr. Eleanor Jameson, Prof. Orkun Soyer, Prof. Arjan Narbad The gut microbiome consists of viruses, bacteria, archaea and eukaryotes. To date research efforts have focused on bacteria, however the gut virome remains underexplored, even thoug

Dr. Eleanor Jameson, Prof. Orkun Soyer, Prof. Arjan Narbad The gut microbiome consists of viruses, bacteria, archaea and eukaryotes. To date research efforts have focused on bacteria, however the gut virome remains underexplored, even thoug

Great news for BiomX, a company developing custom phage therapies to treat microbiome-based diseases, which just raised $32 million in series B financing!